Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07404397 · ClinicalTrials.gov registry record · Phase 2
Comparing Adjuvant Treatments for High Tone Pelvic Floor Dysfunction
A Phase 2 study of High Tone Pelvic Floor Dysfunction, sponsored by University of Michigan.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT07404397 is a Phase 2 study of High Tone Pelvic Floor Dysfunction that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 60 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07404397, a Phase 2 study of High Tone Pelvic Floor Dysfunction, is actively recruiting participants, sponsored by University of Michigan.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The researchers are comparing two treatments for high tone pelvic floor dysfunction (HTPFD) in conjunction with pelvic floor physical therapy (PFPT). The goal of this study is to find out which of two extra treatments works better for people with HTPFD when they also do regular PFPT. First, the researchers will compare a muscle relaxant medicine (cyclobenzaprine IR) to using a vibrating pelvic floor massage wand. Everyone in the study will also do pelvic floor physical therapy. The researchers want to see how these treatments affect pain, sexual health, physical ability, and overall quality of life.
Conditions Studied
Interventions
- DRUG Cyclobenzaprine
- DEVICE Pelvic floor massage wand
- PROCEDURE Pelvic floor physical therapy
Study Locations (1)
Michigan
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2026-02-18 |
| Est. Completion | 2026-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07404397
The ClinicalTrials.gov registry entry for NCT07404397 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with High Tone Pelvic Floor Dysfunction appearing as the primary indexed condition, and to 3 interventions - of which Cyclobenzaprine is the first listed.
NCT07404397 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT07404397 about?
NCT07404397 is a clinical study titled "Comparing Adjuvant Treatments for High Tone Pelvic Floor Dysfunction". The researchers are comparing two treatments for high tone pelvic floor dysfunction (HTPFD) in conjunction with pelvic floor physical therapy (PFPT). The goal of this study is to find out which of two extra treatments works better for people with HTPFD when they also do regular PFPT. First, the rese...
What is the current status of trial NCT07404397?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 60 participants. The study started on 2026-02-18. Estimated completion is 2026-12.
What conditions does trial NCT07404397 study?
This clinical trial studies the following conditions: High Tone Pelvic Floor Dysfunction.
What interventions are being tested in trial NCT07404397?
The interventions under investigation include: Cyclobenzaprine (DRUG), Pelvic floor massage wand (DEVICE), Pelvic floor physical therapy (PROCEDURE).
Who is sponsoring clinical trial NCT07404397?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07404397 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.